rs372625520
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3
The NM_001128203.2(PLAAT3):c.62A>G(p.Tyr21Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001128203.2 missense
Scores
Clinical Significance
Conservation
Publications
- lipodystrophy, familial partial, type 9Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLAAT3 | NM_001128203.2 | c.62A>G | p.Tyr21Cys | missense_variant | Exon 3 of 5 | ENST00000415826.3 | NP_001121675.1 | |
PLAAT3 | NM_007069.3 | c.62A>G | p.Tyr21Cys | missense_variant | Exon 2 of 4 | NP_009000.2 | ||
PLAAT3 | XM_011544741.2 | c.107A>G | p.Tyr36Cys | missense_variant | Exon 2 of 4 | XP_011543043.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152122Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251480 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461824Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 727214 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74318 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.62A>G (p.Y21C) alteration is located in exon 2 (coding exon 2) of the PLA2G16 gene. This alteration results from a A to G substitution at nucleotide position 62, causing the tyrosine (Y) at amino acid position 21 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at